Skip to the page

Data / Drug companies / Aminosalicylate

Aminosalicylate drugs: 4 drugs from 51 companies in the FDA NDC directory

Aminosalicylate is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 84 products in this class from 51 companies, covering 4 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 51Companies
  • 84Products
  • 4Drugs by generic name

Drugs in the Aminosalicylate class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Mesalamine6041
Sulfasalazine1410
Balsalazide disodium99
Olsalazine sodium11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Zydus Lifesciences Limited5tablet, delayed release; capsuleGeneric drugs (ANDA)August 25, 2023
American Health Packaging4tablet, delayed release; capsule, extended releaseGeneric drugs (ANDA)September 6, 2022
Bryant Ranch Prepack4tablet, delayed release; capsuleGeneric drugs (ANDA)June 3, 2023
Takeda Pharmaceuticals America, Inc.4tablet, delayed release; capsuleNew drug applications (NDA)August 29, 2017
Camber Pharmaceuticals, Inc.3capsule, extended release; tablet, delayed releaseGeneric drugs (ANDA)August 13, 2025
Golden State Medical Supply, Inc.3tablet, delayed release; capsule, extended releaseGeneric drugs (ANDA)June 6, 2023
Teva Pharmaceuticals USA, Inc.3tablet; capsule, extended releaseGeneric drugs (ANDA)December 15, 2022
Zydus Pharmaceuticals USA Inc.3tablet, delayed release; capsule, extended releaseGeneric drugs (ANDA)August 13, 2021
A-S Medication Solutions2tabletAuthorized generics (NDA)July 1, 2003
AvPAK2capsule; capsule, extended releaseGeneric drugs (ANDA)January 16, 2023
Bryant Ranch Prepack2tablet; suppositoryGeneric drugs (ANDA)December 15, 2022
Chartwell RX, LLC2tablet, delayed release; tabletGeneric drugs (ANDA)June 3, 2023
Mylan Pharmaceuticals Inc.2tablet, delayed release; tabletAuthorized generics (NDA)May 5, 2005
Pfizer Laboratories Div Pfizer Inc2tablet, delayed release; tabletNew drug applications (NDA)June 20, 1950
Rising Pharma Holdings, Inc.2tablet; suppositoryGeneric drugs (ANDA)November 4, 2025
Sandoz Inc2capsule, extended releaseGeneric drugs (ANDA)July 21, 2026
Sun Pharmaceutical Industries, Inc.2capsule, extended release; tablet, delayed releaseGeneric drugs (ANDA)May 13, 2022
Sunrise Pharmaceutical, Inc.2tablet, delayed release; tabletGeneric drugs (ANDA)December 11, 2025
Viatris Specialty LLC2capsule, gelatin coated; suspensionNew drug applications (NDA)March 24, 2016
Zydus Pharmaceuticals USA Inc.2suppository; capsuleGeneric drugs (ANDA)August 25, 2023
Actavis Pharma, Inc.1suppositoryGeneric drugs (ANDA)April 23, 2021
Actavis Pharma, Inc.1tablet, delayed releaseGeneric drugs (ANDA)March 26, 2018
Alembic Pharmaceuticals Inc.1capsule, extended releaseGeneric drugs (ANDA)November 3, 2022
Alembic Pharmaceuticals Limited1capsule, extended releaseGeneric drugs (ANDA)November 3, 2022
Allergan, Inc.1suppositoryNew drug applications (NDA)January 5, 2001
Amneal Pharmaceuticals LLC1tablet, delayed releaseGeneric drugs (ANDA)February 19, 2025
Ani Pharmaceuticals, Inc.1enemaAuthorized generics (NDA)May 13, 2016
Ani Pharmaceuticals, Inc.1suspensionGeneric drugs (ANDA)May 14, 2026
Aphena Pharma Solutions - Tennessee, LLC1tabletAuthorized generics (NDA)July 1, 2003
Apotex Corp.1capsuleGeneric drugs (ANDA)December 28, 2007
Ascend Laboratories, LLC1capsule, extended releaseGeneric drugs (ANDA)July 16, 2021
Aurobindo Pharma Limited1capsule, extended releaseGeneric drugs (ANDA)March 31, 2023
AvKARE1tablet, delayed releaseGeneric drugs (ANDA)September 25, 2024
Carnegie Pharmaceuticals LLC1capsuleGeneric drugs (ANDA)June 30, 2025
Encube Ethicals, Inc.1suspensionGeneric drugs (ANDA)June 1, 2023
Hikma Pharmaceuticals USA Inc.1capsuleGeneric drugs (ANDA)December 28, 2007
Ingenus Pharmaceuticals, LLC1capsule, extended releaseGeneric drugs (ANDA)September 23, 2024
KLM Laboratories Private Limited1suspensionGeneric drugs (ANDA)September 1, 2026
Lannett Company, Inc.1tablet, delayed releaseGeneric drugs (ANDA)June 3, 2023
Major Pharmaceuticals1tablet, delayed releaseGeneric drugs (ANDA)June 19, 2017
Mylan Pharmaceuticals Inc.1capsule, extended releaseGeneric drugs (ANDA)November 26, 2019
Nordic Pharma, Inc.1suppositoryGeneric drugs (ANDA)June 24, 2019
NorthStar Rx LLC1suppositoryGeneric drugs (ANDA)August 25, 2021
NorthStar RxLLC1tablet, delayed releaseGeneric drugs (ANDA)December 1, 2024
Nuvaila Limited1tablet, delayed releaseGeneric drugs (ANDA)July 1, 2026
PD-Rx Pharmaceuticals, Inc.1capsuleGeneric drugs (ANDA)December 28, 2007
Padagis Israel Pharmaceuticals Ltd1enemaGeneric drugs (ANDA)October 11, 2007
Remedyrepack Inc.1tabletAuthorized generics (NDA)January 28, 2019
Salix Pharmaceuticals, Inc.1capsule, extended releaseNew drug applications (NDA)October 31, 2008
Teva Pharmaceuticals, Inc.1tablet, delayed releaseGeneric drugs (ANDA)August 22, 2024
Upsher-Smith Laboratories, LLC1capsule, extended releaseGeneric drugs (ANDA)June 6, 2023

Dosage forms

Dosage formProductsShare
Tablet, delayed release2529.8%
Capsule, extended release1821.4%
Tablet1113.1%
Capsule1113.1%
Suppository910.7%
Suspension56%
Enema22.4%
Capsule, delayed release22.4%
Capsule, gelatin coated11.2%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.